SCHEMBL24071504

SCHEMBL24071504

O=C(Nc1nc2c(F)cc(F)cc2s1)C1CCNC1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 9/20 0.77
▸ NPC1 O15118 8/20 0.77
▸ MAPT P10636 6/20 0.53
▸ ALDH1A1 P00352 4/20 0.51
▸ MEN1 O00255 4/20 0.51
▸ KMT2A Q03164 4/20 0.51
▸ LMNA P02545 2/20 0.51
▸ AGTR1 P30556 1/20 0.51
▸ OPRK1 P41145 1/20 0.51
▸ HTT P42858 1/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ CHKA P35790 1/20 0.51
▸ POLB P06746 3/20 0.49
▸ PKM P14618 3/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ TDP1 Q9NUW8 2/20 0.49
▸ TP53 P04637 1/20 0.49
▸ GAA P10253 3/20 0.46
▸ TNF P01375 1/20 0.46
▸ CRHBP P24387 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31389079 0.94 RAB9A (0.72) RAB9ANPC1MAPTALDH1A1MEN1
SCHEMBL31389080 0.94 RAB9A (0.72) RAB9ANPC1MAPTALDH1A1MEN1
SCHEMBL25528336 0.94 RAB9A (0.72) RAB9ANPC1MAPTALDH1A1MEN1
SCHEMBL24071516 0.94 RAB9A (0.72) RAB9ANPC1MAPTALDH1A1MEN1
SCHEMBL25528397 0.94 RAB9A (0.72) RAB9ANPC1MAPTALDH1A1MEN1
Hydrochloric Acid SCHEMBL25197545 0.93 RAB9A (0.71) RAB9ANPC1MAPTALDH1A1MEN1
Hydrochloric Acid SCHEMBL31200518 0.93 RAB9A (0.71) RAB9ANPC1MAPTALDH1A1MEN1
Hydrochloric Acid SCHEMBL25218872 0.93 RAB9A (0.71) RAB9ANPC1MAPTALDH1A1MEN1
Hydrochloric Acid SCHEMBL31389072 0.93 RAB9A (0.71) RAB9ANPC1MAPTALDH1A1MEN1
Hydrochloric Acid SCHEMBL25200870 0.93 RAB9A (0.71) RAB9ANPC1MAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203025-A1 ENHANCERS OF PARTICULATE GUANYLYL CYCLASE RECEPTOR A Sanford Burnham Prebys Medical Discovery Institute 2023-06-29 — — US disclosed
US-20230203025-A1 ENHANCERS OF PARTICULATE GUANYLYL CYCLASE RECEPTOR A Sanford Burnham Prebys Medical Discovery Institute 2023-06-29 — — US disclosed
WO-2021243230-A1 ENHANCERS OF PARTICULATE GUANYLYL CYCLASE RECEPTOR A MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2021-12-02 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203025-A1 ENHANCERS OF PARTICULATE GUANYLYL CYCLASE RECEPTOR A GPR119, GUCY1A2, PRKG1 RAB9A 1329/4885NPC1 224/4885MAPT 4047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback